News Releases
Progressive Care Announces Annual Audited 2020 Report Earnings Call and Business Update on April 1st, 2021
MIAMI, March 29, 2021 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care,” the “Company,” “we,” “our”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Thursday, April 1st, 2021.
March 28, 2021
Progressive Care CEO Issues Annual Shareholder Letter
MIAMI, FL, March 3, 2021 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care,” the “Company,” “we,” “our”), a personalized healthcare services and technology company, issues the following Letter to Shareholders from the Chief Executive Officer:
March 3, 2021
Progressive Care Transitions to New Software Platform, Allowing Integration of Data Analytics Business
MIAMI, FL – February 23, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce its transition its software platform to Newleaf, a best-in-class pharmacy software solution produced by leading pharmacy software and technology provider, Keycentrix (Keycentrix.com).
February 24, 2021
Progressive Care Announces Telehealth Partnership with EagleForce Health to Drive myVax™ Digital Passport for COVID-19 Testing and Vaccination
MIAMI, FL – February 16, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce a new partnership with EagleForce Health, LLC to integrate its proprietary telehealth platform (“myVax™”) and develop a platform for the Company’s Digital Passport for COVID-19 Testing and Vaccination results.
February 16, 2021
Progressive Care Announces Record December and Full Year 2020 Performance Data
MIAMI, FL – February 8, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to report performance data for the month of December and the full year of 2020, which featured robust growth in sales and prescriptions, as well as breakout growth in emerging income streams, including 340B administration fees and COVID-19 Rapid Testing services.
February 8, 2021
Progressive Care Completes Expansion, Launches COVID-19 Rapid Testing at New Orlando Location
MIAMI, FL – February 1, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that its new 3,700 square foot Orlando pharmacy has now officially opened for business as a potent full-service location that is also expected to act as a growth hub for rapid results viral testing services, Covid-19 vaccinations, and 340B third-party administration contracting.
February 1, 2021
Progressive Care Announces November 2020 Results, Reports Strong Prescriptions and Covid-19 Rapid Testing Sales
MIAMI, FL – January 8, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020.
January 7, 2021
Progressive Care Completes Move to New Facility, Begins Expansion Into Long-Term Care Pharmacy Market
Miami, FL – December 23, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has completed its move into its new 11,000 sq ft pharmacy space in Hallandale Beach, FL.
December 23, 2020
Progressive Care, Inc. Announces Results of Special Meeting
MIAMI, FLORIDA - December 17, 2020 - On December 14, 2020, Progressive Care, Inc. (the “Company”) held a special meeting of its stockholders (the “Special Meeting”). The record date for stockholders entitled to notice of, and to vote at, the Special Meeting was October 23, 2020. At the close of business on that date, the Company had 470,272,862 shares of common stock, par value $0.0001 (“Common Stock”) outstanding and 51 shares of Series A Super-Voting preferred stock (“Preferred Stock”) outstanding, and entitled to be voted at the Special Meeting. At the Special Meeting, the following four proposals were submitted to the Company’s stockholders:
December 17, 2020
Progressive Care Announces October Growth in Net Revenues as COVID-19 Testing Ramps Up
MIAMI, FL – December 7, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of October, which featured a strong jump in operating margins, significant sequential monthly growth in net revenues, and the establishment of sales growth related to rapid results COVID-19 testing.
December 7, 2020
Investors' Presentation